Core Insights - CARBIOS has suspended its liquidity contract with Natixis ODDO BHF as of January 19, 2026, due to satisfactory liquidity of its shares [2][3]. - As of December 31, 2025, the liquidity account held 12,989 shares and €198,347.09 [2]. - The liquidity contract was established in accordance with the French Financial Market Authority's regulations [3]. Company Overview - CARBIOS is a biotechnology company focused on developing biological solutions for plastics and textiles, aiming to prevent pollution and promote a circular economy [4]. - The company has two main technologies: PET biorecycling and PLA biodegradation, which are being scaled to industrial levels [4]. - CARBIOS collaborates with major brands in various industries, including Nestlé Waters, PepsiCo, and L'Oréal, to enhance product recyclability [4]. Trading Activity - During the semester, there were 3,209 buy-side executions totaling 509,491 shares traded for €4,740,354.18, while sell-side executions totaled 3,538 for 512,000 shares at €4,738,838.30 [6]. - The liquidity account showed a consistent trading volume, indicating active market participation [6].

Core Viewpoint - CARBIOS is committed to advancing the construction of its Longlaville plant, with a revised timeline and significant pre-commercialization contracts in place to support its financing efforts [2][8]. Financing and Project Timeline - A small portion of the financing is still required, with the goal to secure it by the end of Q1 2026, allowing for the plant to be commissioned in the first half of 2028 [5][8]. - The project has secured public funding of €42.5 million and is expected to be financially independent from CARBIOS through non-recourse financing [4][8]. - CARBIOS anticipates having over €55 million in available cash by the end of 2025, providing visibility on its financing horizon for the next twelve months [8]. Commercialization and Market Engagement - In 2025, CARBIOS signed pre-commercialization contracts covering nearly 50% of the production capacity at the Longlaville site, with aims to increase this to 70% soon [3][8]. - The company is actively pursuing commercialization of its technology licenses, having established a strategic partnership with Wankai New Materials for deployment in Asia, and plans to expand into Europe and the Americas [6][12]. Technological and Environmental Commitment - CARBIOS focuses on developing biological solutions for plastic and textile lifecycle management, utilizing enzyme-based processes for PET biorecycling and PLA biodegradation [7]. - The company collaborates with major brands in the cosmetics, food, and apparel sectors to enhance product recyclability and support a circular economy [7].

Group 1 - CARBIOS has released its Interim report for the first half of 2025, which is available for shareholders and the financial community [1] - The company focuses on developing and industrializing biological technologies aimed at reinventing the lifecycle of plastics and textiles [2] - CARBIOS has two main technologies: PET biorecycling and PLA biodegradation, which are currently being scaled up to industrial and commercial levels [2] Group 2 - The industrial demonstration plant for biorecycling has been operational since 2021, with the construction of the world's first biorecycling plant expected to resume before the end of 2025, pending additional funding [2] - CARBIOS collaborates with major brands in the cosmetics, food, and apparel industries to enhance the recyclability and circularity of their products [2] - The company is part of the global community of B Corp™ certified companies, indicating a commitment to transforming business models for the common good [2]

Financial Results - The company reported a solid cash position of €72 million as of June 30, 2025, providing a cash horizon of more than 12 months, thanks to a cost-saving plan executed in the first half of 2025 [2][6] - Revenue for the first half of 2025 was €519,000, compared to €73,000 in the same period of 2024, indicating significant growth [12][27] - The current operating loss improved to €17.6 million from €20 million year-over-year, attributed to reduced operating expenses and increased revenues [14][15] Regulatory Environment Developments - A new decree in France provides financial incentives for incorporating recycled materials into products, offering a €1,000/ton bonus for using biorecycled plastics in sensitive-contact packaging [3][9] - This regulatory change is expected to accelerate customer adoption of CARBIOS' technology, allowing the company to supply high-quality recycled PET (r-PET) at a competitive price [3][9] Longlaville PET Biorecycling Plant Update - The construction of the Longlaville biorecycling plant is expected to resume before the end of 2025, contingent upon securing additional funding [6][9] - The plant is set to be commissioned in the second half of 2027, with significant progress made in securing public funding and interest from private investors [6][9][13] - Pre-sales of products from the future plant are progressing, supported by a favorable regulatory environment [7][9] Licensing and Technological Development - The company remains committed to the commercialization of licenses for its technology, supported by technological maturity and ongoing negotiations with various partners [10] - CARBIOS has secured a significant portion of its raw material supply and signed polymerization contracts, strengthening the project's industrial foundations [7][10] Cash Flow and Financial Position - The net cash consumption for the first half of 2025 was €18.1 million, a decrease from €102.1 million in 2024, reflecting improved cash management [19][30] - Cash and cash equivalents at the end of the period stood at €71.7 million, down from €89.8 million at the beginning of the period [19][30]